Filing Flows › Verastem (VSTM) › Q2 2025
Verastem (VSTM) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 7, 2025
Verastem (VSTM) reported revenue of $2.1M for the second quarter 2025 (Q2 2025), -79% from a year earlier.
Verastem, Q2 2025: revenue $2.1M (-79% year over year), net loss $25.9M, operating cash flow −$32.7M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.1M | — | -79% |
| Operating profit | −$43.8M | — | — |
| Net earnings | −$25.9M | — | — |
| Operating cash flow | −$32.7M | — | — |
What changed
Revenue was $2.1M in Q2 2025, down 79% year over year.
Operating costs exceeded revenue by $43.8M, an operating margin of -2047.9%. Total costs grew 62% against a revenue fall of 79%. The fastest-growing cost line was SG&A (+102%). The quarter ended with a net loss of $25.9M. Non-operating items added $17.8M, -69% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$32.7M. Non-cash charges added back $3.4M of share-based compensation. Working capital and other items used $10.1M.
Questions
What was Verastem's revenue in the second quarter 2025?
Verastem (VSTM) reported revenue of $2.1M for the second quarter 2025 (Q2 2025), -79% from a year earlier.
Source: Verastem 10-Q on SEC EDGAR.